Oramed Pharmaceuticals (Israel) Top Management
| ORMP Stock | 8.85 0.23 2.67% |
Oramed Pharmaceuticals employs about 10 people. The company is managed by 13 executives with a total tenure of roughly 125 years, averaging almost 9.0 years of service per executive, having 0.77 employees per reported executive. Analysis of Oramed Pharmaceuticals' management performance can provide insight into the company performance.
| Nadav Kidron CEO President CEO, Director |
| Kevin Rakin Chairman Chairman of the Board, Independent Director |
Oramed |
Oramed Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of (26.77) % which means that it has lost $26.77 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (78.51) %, meaning that it generated substantial loss on money invested by shareholders. Oramed Pharmaceuticals' management efficiency ratios could be used to measure how well Oramed Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Oramed Pharmaceuticals Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Oramed Pharmaceuticals Price Series Summation is a cross summation of Oramed Pharmaceuticals price series and its benchmark/peer.
Oramed Pharmaceuticals Notable Stakeholders
An Oramed Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Oramed Pharmaceuticals often face trade-offs trying to please all of them. Oramed Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Oramed Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Nadav Kidron | President CEO, Director | Profile | |
| Kevin Rakin | Chairman of the Board, Independent Director | Profile | |
| Mark Hasleton | Vice President - Business Development | Profile | |
| Joshua Hexter | COO, Vice President - Business Development | Profile | |
| Hilla Eisenberg | CFO, Treasurer, Secretary | Profile | |
| Avi Gabay | CFO, Treasurer, Secretary | Profile | |
| Miriam Kidron | Chief Scientific Officer, Director | Profile | |
| Xiaopeng Li | Independent Director | Profile | |
| Leonard Sank | Independent Director | Profile | |
| Xiaoming Gao | Director | Profile | |
| David Slager | Independent Director | Profile | |
| Aviad Friedman | Independent Director | Profile | |
| Ronald Law | Chief Strategy Officer | Profile |
About Oramed Pharmaceuticals Management Performance
The success or failure of an entity such as Oramed Pharmaceuticals often depends on how effective the management is. Oramed Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Oramed management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Oramed management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York. ORAMED PHARMA is traded on Tel Aviv Stock Exchange in Israel.
The data published in Oramed Pharmaceuticals' official financial statements usually reflect Oramed Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Oramed Pharmaceuticals. For example, before you start analyzing numbers published by Oramed accountants, it's critical to develop an understanding of what Oramed Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Oramed space in which it operates.
Please note, the presentation of Oramed Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Oramed Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Oramed Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Oramed Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Oramed Pharmaceuticals' management manipulating its earnings.
Oramed Pharmaceuticals Workforce Analysis
Traditionally, organizations such as Oramed Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Oramed Pharmaceuticals within its industry.Oramed Pharmaceuticals Manpower Efficiency
Return on Oramed Pharmaceuticals Manpower
| Revenue Per Employee | 264K | |
| Revenue Per Executive | 203.1K | |
| Net Loss Per Employee | 1.5M | |
| Net Loss Per Executive | 1.2M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oramed Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Oramed Stock refer to our How to Trade Oramed Stock guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for Oramed Stock analysis
When running Oramed Pharmaceuticals' price analysis, check to measure Oramed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oramed Pharmaceuticals is operating at the current time. Most of Oramed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oramed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oramed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oramed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Stocks Directory Find actively traded stocks across global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |